Shanghai - Delayed Quote CNY
Shanghai Haohai Biological Technology Co., Ltd. (688366.SS)
52.00
+0.28
+(0.54%)
At close: June 13 at 3:00:03 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,679,667
2,679,667
2,634,910
2,103,438
1,750,116
Cost of Revenue
810,879
810,879
781,401
656,515
490,370
Gross Profit
1,868,788
1,868,788
1,853,509
1,446,923
1,259,746
Operating Expense
1,422,594
1,422,594
1,415,132
1,226,752
1,032,151
Operating Income
446,194
446,194
438,377
220,171
227,595
Net Non Operating Interest Income Expense
55,901
55,901
70,436
80,280
93,247
Pretax Income
466,145
466,145
508,260
235,726
382,649
Tax Provision
89,902
89,902
95,991
45,395
35,366
Net Income Common Stockholders
420,447
420,447
416,121
180,470
352,234
Diluted NI Available to Com Stockholders
420,447
420,447
416,121
180,470
352,234
Basic EPS
1.84
1.80
1.75
0.74
1.43
Diluted EPS
1.84
1.80
1.75
0.74
1.43
Basic Average Shares
234,201.75
233,108.06
237,313.83
242,987.89
246,575.29
Diluted Average Shares
234,201.75
233,108.06
237,313.83
242,987.89
246,575.29
Rent Expense Supplemental
--
--
4,652
4,562
--
Total Expenses
2,233,473
2,233,473
2,196,533
1,883,267
1,522,521
Net Income from Continuing & Discontinued Operation
420,447
420,447
416,121
180,470
352,234
Normalized Income
397,730.93
397,730.93
412,149.67
192,842.12
349,344.74
Interest Income
73,962
73,962
77,731
87,883
98,210
Interest Expense
18,061
18,061
7,295
7,603
4,963
Net Interest Income
55,901
55,901
70,436
80,280
93,247
EBIT
484,206
484,206
515,555
243,329
387,612
EBITDA
689,432
689,432
713,410
447,546
550,449
Reconciled Cost of Revenue
810,879
810,879
781,401
656,515
490,370
Reconciled Depreciation
205,226
205,226
197,855
204,217
162,837
Net Income from Continuing Operation Net Minority Interest
420,447
420,447
416,121
180,470
352,234
Total Unusual Items Excluding Goodwill
28,144
28,144
4,896
-15,331
3,182
Total Unusual Items
28,144
28,144
4,896
-15,331
3,182
Normalized EBITDA
661,288
661,288
708,514
462,877
547,267
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
5,427.93
5,427.93
924.67
-2,958.88
292.74
12/31/2021 - 10/30/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ERNA Ernexa Therapeutics Inc.
2.2900
-3.38%
PGEN Precigen, Inc.
1.5200
0.00%
OSTX OS Therapies Incorporated
1.8200
-1.09%
ALLO Allogene Therapeutics, Inc.
1.3400
-4.29%
SLS SELLAS Life Sciences Group, Inc.
1.6600
+0.61%
FATE Fate Therapeutics, Inc.
1.2750
-8.93%
ATYR aTyr Pharma, Inc.
5.20
-4.24%
EYEN Eyenovia, Inc.
2.4400
-8.61%
RXRX Recursion Pharmaceuticals, Inc.
4.9200
-4.84%
KLTO Klotho Neurosciences, Inc.
1.6000
-20.00%